Health Insurance Innovations (HIIQ) PT Raised to $50 at Lake Street Capital Markets; Executing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Health Insurance Innovations (HIIQ) PT Raised to $55 at Canaccord Genuity
March 2, 2018 1:21 AM ESTCanaccord Genuity raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $55.00 (from $39.00) while maintaining a Buy rating.
... MoreHealth Insurance Innovations (HIIQ) PT Raised to $45 at Craig-Hallum; 'More to Come'
March 1, 2018 10:49 AM ESTCraig-Hallum raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $45.00 while maintaining a Buy rating.
Analyst George Sutton said results were great and the outlook positive with more to come.
... MorePre-Open Movers 03/01: (NVAX) (DDD) (HIIQ) Higher; (PTLA) (PDCO) (BOX) Lower (more...)
March 1, 2018 9:24 AM ESTToday's Pre-Open Movers
Novavax, Inc., (Nasdaq: NVAX) 29.9% HIGHER; announced positive top-line results from its Phase 1/2 clinical trial in older adults of its NanoFlu recombinant influenza vaccine, which includes its proprietary Matrix-M adjuvant, compared to the leading licensed egg-based, high-dose influenza vaccine for older adults (IIV3-HD).
Portola Pharma (NASDAQ: PTLA) 23.2% LOWER; reported Q4 EPS of ($1.41), $0.05 better than the analyst estimate of ($1.46). Collaboration and License revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.2... More
Health Insurance Innovations (HIIQ) PT Raised to $60 at Cantor Fitzgerald, 'Fundamentals Accelerating'
March 1, 2018 5:34 AM ESTCantor Fitzgerald raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $60.00 (from $38.00) while maintaining a Overweight rating.
Analyst Steven Halper comments "We expect HIIQ to continue to benefit from solid demand for its alternative individual health insurance products. We... More
Raymond James Upgrades Health Insurance Innovations (HIIQ) to Outperform
March 1, 2018 5:30 AM ESTRaymond James upgraded Health Insurance Innovations (NASDAQ: HIIQ) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Health Insurance Innovations click here. For more ratings news on Health Insurance Innovations click here.
Shares of Health Insurance Innovations closed at $31.20 yesterday.
... MoreAfter-Hours Stock Movers 02/28: (NVAX) (DDD) (QEP) Higher; (PTLA) (BOX) (MNST) Lower (more...)
February 28, 2018 5:56 PM ESTToday's After-Hours Movers
Novavax, Inc., (Nasdaq: NVAX) 24% HIGHER; announced positive top-line results from its Phase 1/2 clinical trial in older adults of its NanoFlu recombinant influenza vaccine, which includes its proprietary Matrix-M adjuvant, compared to the leading licensed egg-based, high-dose influenza vaccine for older adults (IIV3-HD).
Portola Pharma (NASDAQ: PTLA) 23.2% LOWER; reported Q4 EPS of ($1.41), $0.05 better than the analyst estimate of ($1.46). Collaboration and License revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.2 million. Provides... More
Health Insurance Innovations (HIIQ) Tops Q4 EPS by 3c
February 28, 2018 4:13 PM ESTHealth Insurance Innovations (NASDAQ: HIIQ) reported Q4 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $69.5 million versus the consensus estimate of $59.61 million.
GUIDANCE:
Health Insurance Innovations sees Q1 2018 EPS of $2.45-$2.55. Health Insurance... More
